BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 20, 2025
Home » Authors » John Fox

Articles by John Fox

Ketamine discovery may yield fast-acting antidepressants

March 5, 2018
By John Fox

Ketamine discovery may yield fast-acting antidepressants

March 2, 2018
By John Fox
HONG KONG – A Chinese study has shown for the first time that the powerful antidepressant effects of ketamine are due to blockade of rapid neuronal firing in the brain's lateral habenula (LHb) region. Such blockade was found to disinhibit reward centers and relieve depressive symptoms rapidly in animal models.
Read More

Nanorobots deliver blood-curdling cancer therapy

Feb. 28, 2018
By John Fox
HONG KONG – Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger.
Read More

Organ on a chip provides insight into hepatitis B virus

Feb. 28, 2018
By John Fox
HONG KONG – Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases.
Read More

Nanorobots deliver blood-curdling cancer therapy

Feb. 23, 2018
By John Fox

Nanorobots deliver blood-curdling cancer therapy

Feb. 23, 2018
By John Fox
Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger.
Read More

Organ on a chip gives insight into hepatitis B virus

Feb. 22, 2018
By John Fox

Organ on a chip provides insight into hepatitis B virus

Feb. 22, 2018
By John Fox
Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases.
Read More

GWAS in Chinese population implicates immune system in Alzheimer's disease

Feb. 20, 2018
By John Fox

GWAS in Chinese population implicates immune system in Alzheimer's disease

Feb. 15, 2018
By John Fox
A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.
Read More
Previous 1 2 … 24 25 26 27 28 29 30 31 32 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing